These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9441132)

  • 1. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema.
    Knight KR; Burdon JG; Cook L; Brenton S; Ayad M; Janus ED
    Respirology; 1997 Jun; 2(2):91-5. PubMed ID: 9441132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis.
    Ayad MS; Knight KR; Burdon JG; Brenton S
    Respirology; 2003 Jun; 8(2):175-80. PubMed ID: 12753532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
    Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
    Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S; Welte T
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor.
    Evans MD; Pryor WA
    Am J Physiol; 1994 Jun; 266(6 Pt 1):L593-611. PubMed ID: 8023948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum].
    Braun J; Welle S; van Wees J; Winterhoff R; Wood WG; Dalhoff K; Wiessmann KJ
    Dtsch Med Wochenschr; 1990 Jun; 115(23):889-94. PubMed ID: 2191843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
    Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
    Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
    Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-antitrypsin-deficiency-related emphysema.
    Barker AF
    J Am Board Fam Pract; 1992; 5(5):489-93. PubMed ID: 1414450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of neutrophils on the lung.
    Gadek JE
    Am J Med; 1992 Jun; 92(6A):27S-31S. PubMed ID: 1320328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of lung diseases with antiproteases].
    Vogelmeier C; Buhl R
    Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients.
    King MB; Campbell EJ; Gray BH; Hertz MI
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):966-71. PubMed ID: 8143063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1 antitrypsin deficiency in emphysema.
    Khan H; Salman KA; Ahmed S
    J Assoc Physicians India; 2002 Apr; 50():579-82. PubMed ID: 12164415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
    Sallenave JM; Donnelly SC; Grant IS; Robertson C; Gauldie J; Haslett C
    Eur Respir J; 1999 May; 13(5):1029-36. PubMed ID: 10414400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of a rare variant of alpha-1-antitrypsin, phenotype P(i) EFranklin S, a poor inhibitor of human neutrophil elastase.
    Cook L; Knight KR; Burdon JG; Brenton S; Hunt JM
    Res Exp Med (Berl); 1997; 196(6):355-62. PubMed ID: 9089884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.